Patent ID: 9428813
Filing Date: 2016-08-30
CPC Classification: C12Q

Claim Text:
1. A method, consisting of: obtaining a sample comprising genomic DNA from a subject at risk of acquiring or suspected to have an adrenocortical tumor; isolating genomic DNA from the sample; and measuring a level of methylation in one or more genomic CpG dinucleotide sequences within one or more of malignant adrenocortical tumor-related molecules in genomic DNA isolated sample obtained from the subject at risk of acquiring or suspected to have an adrenocortical tumor, wherein the one or more malignant adrenocortical tumor-related molecules comprise at least one of SLC16A9, IL13RA2, HTR2B, CCNB2, RARRES2, KCTD12, KIRREL, SYNGR1 or NTNG2.